AngioDynamics Reports Fiscal 2020 First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
AngioDynamics (ANGO) Tops Q1 EPS by 4c, Revenues Miss; Offers FY20 EPS Guidance Below Consensus, FY20 Mid-Point Revenue View Above Consensus
October 3, 2019 6:05 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q1 EPS of $0.08, $0.04 better than the analyst estimate of $0.04. Revenue for the quarter came in at $66 million versus the consensus estimate of $67.52 million.
Fiscal 2020 First Quarter Highlights
Net sales of $66.0 million, an increase of 3.3% year over yearGross margin increased 170 basis points year over year to 57.9%GAAP loss per share of $0.03; adjusted earnings per... More